These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35563890)

  • 1. Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis.
    Endaryanto A; Nugraha RA
    Cells; 2022 May; 11(9):. PubMed ID: 35563890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
    Huang HH; Xu C; Liu L; Chai RN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis.
    Valero A; Ibáñez-Echevarría E; Vidal C; Raducan I; Castelló Carrascosa JV; Sánchez-López J
    Immunotherapy; 2022 Jun; 14(9):683-694. PubMed ID: 35465692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Observation and analysis of systemic reactions to house dust mite subcutaneous immunotherapy in 362 patients with allergic rhinitis].
    Xue JR; Ma J; Qiu CY; Hu ZB; Jiang X; Pan M; Lu MP; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):445-451. PubMed ID: 32842357
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study.
    Hamada M; Saeki K; Tanaka I
    Allergol Int; 2023 Oct; 72(4):573-579. PubMed ID: 36918306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dust mite component Analysis: Identifying key allergens components for effective immunotherapy in allergic rhinitis.
    Huang J; Xiang R; Tan L; Deng Y; Tao Z; Zhang W; Xu Y
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111111. PubMed ID: 37925948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
    Jutel M; Klimek L; Richter H; Brüggenjürgen B; Vogelberg C
    Allergy; 2024 Apr; 79(4):1042-1051. PubMed ID: 38429981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases.
    Yang Y; Ma D; Huang N; Li W; Jiang Q; Wang Y; Wang X; Yang L; Zhu R
    Ital J Pediatr; 2021 Apr; 47(1):101. PubMed ID: 33892756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
    Rønborg S; Johnsen CR; Theilgaard S; Winther A; Hahn-Pedersen J; Andreasen JN; Olsen J
    J Med Econ; 2016 Aug; 19(8):735-41. PubMed ID: 26909663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling.
    Xie S; Fan R; Tang Q; Cai X; Zhang H; Wang F; Xie S; Gao K; Zhang J; Xie Z; Jiang W
    Front Immunol; 2021; 12():805404. PubMed ID: 35095890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-depot house-dust mite allergen extract for Chinese with allergic rhinitis and asthma.
    Li X; Wang X; Lin X; Xu G; Tao Z; Jiang W; Cheng L; Guo Y; Lai H; Shen K
    Am J Rhinol Allergy; 2016 May; 30(3):201-8. PubMed ID: 27216351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented type 2 inflammatory response in allergic rhinitis patients experiencing systemic reactions to house dust mite subcutaneous immunotherapy.
    Ji P; Yang L; Zhu L; Hu L; Wang Y; Shi C; Jiang Q; Huang N; Yang Y; Chen H; Zhu R
    Pediatr Allergy Immunol; 2024 Aug; 35(8):e14207. PubMed ID: 39092594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of subcutaneous immunotherapy in allergic rhinitis children sensitive to dust mites.
    Lin Y; Liu J; He J; Wu L; Li S; Cheng B; Shao Y; Zhang Y; Wang Y; Tang L; Chen Z
    Allergol Immunopathol (Madr); 2023; 51(1):84-91. PubMed ID: 36617826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indonesia-Based Study of the Clinical and Cost-Saving Benefits of Subcutaneous Allergen Immunotherapy for Children with Allergic Rhinitis in Private Practice.
    Endaryanto A; Nugraha RA
    Cells; 2021 Jul; 10(7):. PubMed ID: 34360010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of semi-depot house dust mite allergen extract in children and adolescents with allergic rhinitis and asthma.
    Xiang L; Liu F; Zhi L; Jiang W; Liu C; Xie H; Zhou X; Sun Y; Zheng Y; Zhu R; Tao Z; Xia W; Lai H; Wei Q; Cheng L; Tang Y; Xu R; Huang H; Zhou Q; Chang P
    Immunotherapy; 2021 Feb; 13(3):227-239. PubMed ID: 33317341
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
    Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X
    Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis].
    You SH; Qin XY; Xu C; Qiu X; Luan ZL; Jia HX; Wang HT
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):689-693. PubMed ID: 29771014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.